Clinical Trials

SARC-005: A phase II trial of ABSK043, an oral PD1 inhibitor, in patients with selected sarcomas

Link : https://www.clinicaltrials.gov/ct2/show/NCT07014137
Status : RECRUITING
Population : Angiogenic sarcomas (EHE, intimal sarcomas, H&N angiosarcomas)
Description : ABSK043: 800mg PO BID
PI : A. Razak
Centers Opened : PMH
Phase : II
IIST/Pharma : IIST